Skip to main content

Closed

PSTV: Plus Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-10.5% / yr

Operating margin-364.4%

ROIC-148.8%

Financially safe

Stretched

Debt / equity0.06×

Interest coverage-6.1×

Current ratio2.27×

Plus Therapeutics, Inc.

PSTVNASDAQ Capital Market·USD·Closed

Plus Therapeutics, Inc.

PSTVNASDAQ·USD·Closed

$3.87

+6.03%

$3.87

+$0.22 (6.03%)

52W Range

5thpctl

Volume

0.59×avg

Mkt Cap

9.36MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.59×avg

Market Cap

9.36MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings